The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

While the CDDF Annual Conference 2026 is in full swing, we are thrilled to announce the publication of our latest white paper: “Innovative oncology trial designs: Time to act – A review with recommendations of the Cancer Drug Development Forum.”

This paper was largely informed and inspired by the insights shared during the CDDF hybrid workshop, ‘Innovative Oncology Trial Designs,’ held in September 2023. It provides a comprehensive review of recent innovations in trial designs, study endpoints, and relevant regulatory guidelines, alongside recommendations for the field.

📖 Read the full publication here: https://cddf.org/wp-content/uploads/2026/02/202602_INNOVATIVE-ONCOLOGY-TRIAL-DESIGNS_TIME-TO-ACT.pdf

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

Privacy Policy

info@cddf.org
Tel: +32 2 880 62 70